F Meneghetti
Overview
Explore the profile of F Meneghetti including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
138
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bellucci M, Frigerio M, Castellano C, Meneghetti F, Sacchetti A, Volonterio A
Org Biomol Chem
. 2017 Dec;
16(4):521-525.
PMID: 29210413
A collection of systematically substituted 3-cyclo-butylcarbamoyl hydantoins was synthesized by a regioselective multicomponent domino process followed by easy coupling reactions. Calculations, NMR studies and X-ray analysis show that these scaffolds...
2.
Maggio B, Raffa D, Raimondi M, Plescia F, Trincavelli M, Martini C, et al.
Eur J Med Chem
. 2012 Jul;
54:709-20.
PMID: 22795832
A series of isochromeno[4,3-c]pyrazole-5(1H)-one derivatives 7b-h were prepared and tested at 10 μM for their ability to displace specific [(3)H]flunitrazepam from bovine brain membranes. The substitution pattern of the above...
3.
Tibolla G, Norata G, Artali R, Meneghetti F, Catapano A
Nutr Metab Cardiovasc Dis
. 2011 Sep;
21(11):835-43.
PMID: 21943799
Aims: This short review aims at summarizing the current information on Proprotein Convertase Subtilisin/Kexin type 9 (PCSK9) structure and function focusing also on the therapeutic possibilities based on the inhibition...
4.
Artali R, Marchini N, Meneghetti F, Cavazzini D, Cassetta A, Sassone C
Acta Crystallogr D Biol Crystallogr
. 2005 Apr;
61(Pt 4):481-4.
PMID: 15805604
The crystallographic structure of an engineered flavodoxin mutant from Desulfovibrio vulgaris has been analysed. Site-directed mutagenesis was used to substitute serine 35 with a cysteine to provide a possible covalent...
5.
Artali R, Bombieri G, Meneghetti F, Nava D, Ragg E, Stradi R
Farmaco
. 2003 Sep;
58(9):883-9.
PMID: 13679183
The structural characteristics of an immunostimulating agent (3-(5-thioxo-L-prolyl)-L-thiazolidine-4-carboxylic acid) have been established using a combination of 1H and 13C NMR spectroscopy, molecular mechanic calculations (in vacuo and in solution) and...
6.
Saia M, Castoro M, Meneghetti F, Massarotto E, Narne E, Zignol M, et al.
G Ital Med Lav Ergon
. 2003 Jan;
24(4):438-40.
PMID: 12528351
A ten years retrospective study was carried out among the personnel of Padua Hospital to determine the rate of occupational exposure to blood and body fluids. 4738 injuries occurred between...
7.
Da Ros L, Meneghetti F, Nasci C
Mar Environ Res
. 2002 Nov;
54(3-5):817-22.
PMID: 12408656
A field study was carried out in the Lagoon of Venice (north-east Italy) with the aim of evaluating the potential use of lysosomal destabilisation as a biomarker of anthropogenic stress...
8.
Trevenzoli M, Cattelan A, Rea F, Sasset L, Semisa M, Lanzafame M, et al.
J Infect
. 2002 Oct;
45(3):173-9.
PMID: 12387774
Objectives: Highly active antiretroviral therapy (HAART) produces a rapid decline in plasma HIV-1 RNA levels with concomitant immune reconstitution. Probably due to the enhanced immune function, shortly after starting HAART,...
9.
Cattelan A, Trevenzoli M, Sasset L, Sgarabotto D, Lanzafame M, Meneghetti F
J Infect
. 2002 Mar;
43(4):246-9.
PMID: 11869062
We describe two cases of toxic epidermal necrolysis developed during an antiretroviral therapy regimen containing nevirapine. It seems likely that the poor adherence to the dose escalation regimen of nevirapine...
10.
Cattelan A, Calabro M, Gasperini P, Aversa S, Zanchetta M, Meneghetti F, et al.
J Natl Cancer Inst Monogr
. 2001 Feb;
(28):44-9.
PMID: 11158206
Background: Kaposi's sarcoma (KS) is the most common cancer seen in subjects with acquired immunodeficiency syndrome (AIDS). KS etiology and pathogenesis are still ill defined, and no definite improvement in...